These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23124277)

  • 1. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
    Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
    Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.
    Kim MK; Park SW; Kim SK; Park HJ; Eun YG; Kwon KH; Kim J
    J Korean Med Sci; 2012 Nov; 27(11):1333-8. PubMed ID: 23166414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
    Park SW; Kim MK; Kwon KH; Kim J
    Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
    Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
    Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
    Veltkamp M; van Moorsel CH; Rijkers GT; Ruven HJ; Grutters JC
    Tissue Antigens; 2012 Jan; 79(1):25-32. PubMed ID: 22150367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.
    Opsal MA; Våge DI; Hayes B; Berget I; Lien S
    Gene; 2006 Dec; 384():45-50. PubMed ID: 16950576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 10 rs10004195 variation may be protective against Bacillus Calmette-Guérin osteitis after newborn vaccination.
    Korppi M; Teräsjärvi J; Lauhkonen E; Huhtala H; Nuolivirta K; He Q
    Acta Paediatr; 2021 May; 110(5):1585-1590. PubMed ID: 33314255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
    Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
    Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of IGF1R is associated with papillary thyroid carcinoma in a Korean population.
    Cho SH; Kim SK; Kwon E; Park HJ; Kwon KH; Chung JH
    J Interferon Cytokine Res; 2012 Sep; 32(9):401-6. PubMed ID: 22909219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?
    Boufraqech M; Fassassi C; Kebebew E
    Endocrine; 2013 Feb; 43(1):10-1. PubMed ID: 23138464
    [No Abstract]   [Full Text] [Related]  

  • 15. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
    Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
    Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive polymorphism in the porcine Toll-like receptor 10 gene.
    Bergman IM; Edman K; Ekdahl KN; Rosengren KJ; Edfors I
    Int J Immunogenet; 2012 Feb; 39(1):68-76. PubMed ID: 22077964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.
    Kim SK; Park HJ; Seok H; Jeon HS; Kim JW; Chung JH; Kwon KH; Woo SH; Lee BW; Baik HH
    Anticancer Res; 2013 May; 33(5):2205-10. PubMed ID: 23645777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.
    Brenner AV; Neta G; Sturgis EM; Pfeiffer RM; Hutchinson A; Yeager M; Xu L; Zhou C; Wheeler W; Tucker MA; Chanock SJ; Sigurdson AJ
    PLoS One; 2013; 8(3):e57243. PubMed ID: 23520464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.
    Kurtulmus N; Duren M; Ince U; Cengiz Yakicier M; Peker O; Aydın O; Altiok E; Giray S; Azizlerli H
    Endocrine; 2012 Oct; 42(2):404-10. PubMed ID: 22426956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.